Day: February 25, 2024

5E Advanced Materials Advances Closer to Initial Commercial Production

Figure 1 Photo of 5E lab assistant testing boric acid head-grade. Figure 2 Photo of wellfield DCS Feb 2024. Figure 3 Photo of 5E investor booth at Mines and Money Miami conference. Measurable progress continues towards near-term plant completion Company remains on track to commence commercial operations in CY Q2 2024 at the 5E Boron Americas Complex in California HESPERIA, Calif., Feb. 25, 2024 (GLOBE NEWSWIRE) — 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) (5E or the Company), a boron and lithium company with U.S. government Critical Infrastructure designation for its 5E Boron Americas Complex, provided an update on mining operations and related activities as it moves closer to initial production at the Company’s 5E Boron Americas Complex. “This is an exciting time for all stakeholders of the Company...

Continue reading

NOVONIX Announces Participation in Upcoming Investor Events

BRISBANE, Australia, Feb. 26, 2024 (GLOBE NEWSWIRE) — NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX”), a leading battery materials and technology company, today announced that members of the executive team are scheduled to participate in the following upcoming investor events in February and March 2024: Baird 2024 Vehicle Technology & Mobility Conference to be held virtually on February 29, 2024; and Gabelli Funds 15th Annual Specialty Chemical Symposium to be held March 14, 2024, in New York City. NOVONIX management will be available to host one-on-one and group investor meetings during the conferences. Presentation materials and available webcast links will be available prior to each event on the NOVONIX investor relations website. This announcement has been authorized for release by NOVONIX Chairman, Admiral Robert...

Continue reading

Yintai to Acquire Osino in an All-Cash Transaction for C$368 million

VANCOUVER, British Columbia, Feb. 25, 2024 (GLOBE NEWSWIRE) — Yintai Gold Co., Ltd (000975.CN) (“Yintai“) and Osino Resources Corp. (TSX:OSI.V) (NSX:OSN) (FSE:RSR1) (“Osino“) are pleased to announce that they have entered into a binding arrangement agreement (the “Yintai Arrangement Agreement“), pursuant to which Yintai will acquire all of the outstanding common shares of Osino (each, an “Osino Common Share“) by way of a plan of arrangement (the “Yintai Arrangement“), for cash consideration of C$1.90 for each Osino Common Share, valuing Osino at approximately C$368 million. At closing of the Yintai Arrangement, Osino’s portfolio will consist only of gold related assets located in Namibia, primarily the Twin Hills Gold Project in central Namibia as well as exploration projects...

Continue reading

New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies

Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year consumed without an allergic reaction The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies Allergic reactions can be life-threatening and it is estimated that food-related anaphylaxis results in 30,000 medical events treated in emergency rooms in the U.S. each year1-3 Basel, 25 February 2024 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today data from Stage 1 of the National Institutes of Health (NIH)-sponsored pivotal Phase III OUtMATCH study evaluating the efficacy and safety of Xolair® (omalizumab) in patients allergic to peanuts and at least two other common foods...

Continue reading

Tenaris to Commence a USD 300 million Second Tranche of its USD 1.2 Billion Share Buyback Program

LUXEMBOURG, Feb. 25, 2024 (GLOBE NEWSWIRE) — Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) (“Tenaris”) announced today that pursuant to its Share Buyback Program (the “Program”) announced on November 1, 2023, covering up to $1.2 billion to be executed in the open market with the intent to cancel the ordinary shares acquired through the Program, Tenaris has entered into a non-discretionary buyback agreement with a primary financial institution (the “Bank”). The Bank will make its trading decisions concerning the timing of the purchases of Tenaris’s ordinary shares independently of and uninfluenced by Tenaris and will act in compliance with applicable rules and regulations, including the Market Abuse Regulation 596/2014 and the Commission Delegated Regulation (EU) 2016/1052 (the “Regulations”). Under the buyback agreement,...

Continue reading

Adamas One Corp. Provides Shareholder Update

SCOTTSDALE, Ariz., Feb. 24, 2024 (GLOBE NEWSWIRE) — Adamas One Corp. (Nasdaq: JEWL) (“Adamas One,” “Adamas” or the “Company”), The Original Lab-Grown Diamond Company™, a high-tech company that leverages proprietary technology to produce high-quality, single-crystal, Lab-Grown Diamonds for jewelry and diamond materials for technology and other industrial uses, provides a shareholder update from our CEO below: Upon closing out our first year as a publicly traded company, listed on the NASDAQ exchange, we wanted to reach out to you, our shareholders, with an update on our business and to thank you for both your support and patience. Being a young company listed in a difficult market has been challenging, but we learned, adjusted and now we are looking forward to a good year ahead. At Adamas One Corp, our strategy to build a...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.